This two-way influence creates a dynamic loop where diet, microbiome, and behavior all play a role in modulating GLP-1 secretion
The choice of GLP-1 should be individualized based on several factors: Your treatment goals: Consider whether the primary aim is controlling blood glucose levels, weight loss, or reducing cardiovascular risk
[Article] [PubMed] [PMC]84
Adjustments to concomitant medicationsparticularly sulphonylureas, insulin, or antihypertensive agentsmay be necessary
Lastly, the sample size, while adequately powered for a composite endpoint design [57], can be improved in subsequent studies based on the data from the current one
- Support the skin barrier